Degradation study of copolymers of PLLGA to be used as potential polymeric matrix in coronary stents

  • M.J. Valarezo-Ulloa
  • J.I. Chairez-Oria
  • G. Martínez-Mejía
  • B.E. García-Pérez
  • J.M. del Río
  • C. Gómez-Yañez
  • M. Corea
Keywords: PLLGA copolymers, degradation, desorption, prednisone, kinetic, cytotoxicity, polymeric stent


In this work, three types of poli(L-lactic-co-glycolic acid) copolymers (PLLGA) with different lactide to glycolide ratio (70:30, 80:20 and 90:10 %wt.L-LA:%wt.GA) were synthesized. The materials were characterized by known techniques. The degradation study of PLLGA was made in saline solution and followed by molecular weight change and mass loss percentage. The results showed that PLLGA degradation followed a first order kinetic. Prednisone (immunosuppressive drug) was incorporated into polymeric matrix. The release process was quantified by drug concentration change in the saline solution using UV spectroscopy at 240nm. In this way, diffusion coefficients of prednisone into copolymers were calculated. The results showed that prednisone released was governed by two phenomena: diffusion and degradation. The drug released kinetic was adjusted at two models proposed for biodegradable systems: the model of Higuchi and the model of Charlier. Drug diffusion coefficients were higher in the copolymers with higher percentage of glycolic acid, and they were increasing as the degradation process was progressing. The cytotoxicity assay evidenced that PLLGA copolymers and PLLGA degradation products were not toxic in endothelial cells. Finally, a 3D printer was built and programmed to explore the stent fabrication to be used as potential polymeric matrix in coronary stents.


An YH, Woolf SK, Friedman RJ. Pre-clinical in vivo evaluation of orthopeadic bioabsorbable devices (2000). Biomaterials.21, 2635-2652.
Aoyagi S, Onishi H, Machida Y. (2007) Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. International Journal of Pharmaceutics.330, 138–145.
Avgoustakis K. Polylactic-co-glycolic acid (PLGA). Encyclopedia of Biomaterials and Biomedical Engineering. Second edition. 2005.
Brammer KS, Oh S, Gallagher JO, Jin S. (2008) Enhanced cellular mobility guided by TiO2 nanotube surfaces. Nano Letters. 8. 786–793.
Carter BK, Wilkes GL. Some morphological investigations on an absorbable copolyester biomaterial based on glycolic and lactic acid. Polymers as Biomaterials. New York. Plenum Press. 1984.pp.67-92.
Chabot F, Vert M, Chapelle S, Granger P. (1938). Configuration structures of lactic acid stereocopolymers as determined by C-H n.m.r. Polymer.24. 53-60.
Charlier A, Leclerc B, Couarraze G. (2000) Release of mifepristone from biodegradable metrices: experimental and theoretical evaluation. International Journal of Pharmaceutics. 200, 115-120.
Chiu FY, Chen CM, Lin Chien-Fu J, Lo WH. (2002). Cefuroxime impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. Journal of Bone and Joint Surgery. 84,759–762.
Cholopek J, Morawska-Chochol A, Paluszkiewicz C, Jaworska J, Kasperczyk J, Dobrzynski P. (2009). FTIR and NMR study of poly(lactide-co-glycolide) and hydroxyapatite implant degradation under in vivo conditions. Polymer Degradation and Stability. 94, 1479-1485.
Colthup NB, Daly LH, Wiberley S. E. (1975). Carbonyl compounds. In introduction to infrared and Raman Spectroscopy. Academic Press Inc. pp 278-310.
Dobrzynski P, Li S, Kasperczk J, Bero M, Gase G, Vert M.(2005). Structure property realationship of copolymers obtained by ring-opening polymerization of glycolide and Ɛ-caprolactone. Part 1. Synthesis and characterization. Biomacromolecules. 6, 483-488
Dunn R.L. (1995) Clinical application and update on the poly (α-hydroxy acids).In Hollinger J.O. (ed) Biomedical Applications of Biodegradable Polymers CRC Press, Boca Raton 17-31.
Eberhart R.C, Su S.H, Kytai T.N, Zilberman M, Liping T.(2003). Bioresorbable polymeric stents: current status and future promise. Journal Biomaterial Science Polymer.14, 299–312.
Eubeler J.P, Bernhard M, Knepper T.P. (2010). Environmental biodegradation of synthetic polymers II. Biodegradation of different polymer groups. Trends in Analytical Chemistry. 29, 84-100.
Eubeler JP, Bernhard M, Zok, S, Knepper TP. (2009). Environmental biodegradation of synthetic polymers I. Test methodologies and procedures. Trends in Analytical Chemistry. 28. 1057-1072.
Fernández J, Etxeberria A, Sarasua J.R. (2015). In vitro degradation studies and mechanical behavior of poly (ε-caprolactone-co-δ-valerolactone) and poly(ε-caprolactoneco-L-lactide) with random and semi-alternating chain microstructures. European Polymer Journal.7, 585–595.
Fernández J, Larranaga A, Etxeberria A, Sarasua J.R. 2016. Ethylene brassylate-co-δ- hexalactone biobased polymers for application in the medical field: synthesis, characterization and cell culture studies. RSC Advances. 6, 22121–22136.
Fischer EW, Sterzel HJ. Wegner G. (1973). Investigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactions. Kolloids-Zeitschrift und Zeitschrift fur Polymer. 251, 980-990.
Fredenberg S, Wahlgren M, Reslow M, Axelsson A. (2011). The mechanisms of drug release in poly(lactic-co-glycolic acid) based drug delivery systems-A review. International Journal of Pharmaceutics. 415,34-52.
Fukuzaki H, Yoshida M, Asano M, Kumakura M. (1990). In vivo characteristic of low-molecular weight copoly(L-lactic acid/DL hydroxyisocaproic acid) with paraolic-type and S-type degradation patterns. Macromolecular Chemistry.191,731-736.
Gilding D, Reed A.(1979). Biodegradable polymers for use in surgery-polyglycolic/poly(actic acid) homo- and copolymers:1. Polymer; 20,1459-1464.
Heller J, Trescony PV. (1979). Controlled drug released by polymer dissolution II- enzyme mediated delivery devices. Journal of Pharmaceutical Science.;68,919-921.
Hendricks KJ, Lane D, Burd TA, Lowry KJ, Day D, Phaup JG. (2001). Elution characteristics of tobramycin from polycaprolactone in a rabbit model. Clinical Orthopaedics and Related Research. 329, 418–426.
Hernández MR y Cañas JC. (2006) Citotoxicidad in vitro: sistema para la evaluación de biomateriales y equipos médicos implantables en Cuba. Revista CENIC Ciencias Biológicas.37, 173-176.
Higuchi T. (1963). Mechanism of suspending action mediation. Theoretical analysis of rate of release of solid drug dispersed in solid materials. Journal of Pharmaceutical Science. 52, 1145-1149.
Higuchi T. (1961) Rate of release of medicaments from ointment bases containing drug in suspensions. Journal of Pharmaceutical Science. 50, 874-875.
Huang Y, Antony HC, Wen Xu, Subbu V. (2014). Drug-eluting biostable erodible stents. Journal of Controlled Release. 193, 188-201.
Jang YL, Yun UJ, Lee MS, Kim MG, Son S, Lee K, Chae SY, Lim DW, Kim HT, Kim SH, Jeong JH. (2012). Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression. International Journal Pharmaceutics.434, 488–493.
Joshi A, Himmel KJ. (1991). Dynamics of controlled release from bioerodible matrices. Journal of Controlled Release.15,95-104.
Kataoka K, Harada A, Nagasaki Y. (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Advanced Drug Delivery Reviews. 47, 113-31.
Kister G, Cassanas G, Vert M. (1998). Effect of morphology, conformation and configuration on the IR and Raman spectra of various poly (lactic acids). Polymer.39, 267-273.
Kiyukhin MV. (2014). Active drug released systems: current status, applications and perspectives. Current Opinion in Pharmacology.18, 69-75.
Klose D, Siepmann F. (2012). Modeling of diffusion controlled drug delivery. Biomaterials. 354, 95-103.
Kukreja N, Onuma Y, Serruys PW. (2009). Future directions of drug-eluting stents. Journal of Interventional Cardiology. 22, 96–105.
Kumar A, Ahuja R, Bhati P, Vashisth P, Bhatnagar N. (2019). Design methodology of a ballon expandable polymeric stent. Journal of Biomedical Engineering Medical Devices.4, 1-17.
Langer R. (1990). New methods of drug delivery. Science.249, 1527-33.
Li. S. Synthetic biodegradable medical polyesters. Science and Principles of Biodegradable and Bioresorbable Medical Polymers. 207213th Edition; 2017 pp. 37-77.
Loira-Pastoriza C, Todoroff J, Vanbever R. (2014). Delivery strategies for sustained drug release in the lungs. Advanced Drug Delivery Reviews.75, 81–91.
Ma X, Oyamada S, Gao F, Wu T, Robich MP, Wu H, Wang X, Buchholz B, McCarthy S, Gu Z, Bianchi CF, Sellke FW, Laham R. (2011). Paclitaxel/Sirolimus combination coated drug-eluting stent: In vitro and in vivo drug release studies. J Pharmac Biomedical Anal .54, 807-11.
Makadia HK, Siegel SJ. (2011) Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymer (Basel).3, 1377–97.
Mauduit J, Bukh N,Vert M. (1993). Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively: II. The case of gentamycin sulfate in high molecular weight poly (DL-lactic acid) and poly (L-lactic acid). Journal of Control Release.23, 221-230.
Mauduit J, Bukh N,Vert, M. (1993). Gentamycim/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. the case of gentamycin base and gentamycin sulfate in poly (DL-lactic acid) oligomers. Journal of Control Release. 23, 2092-2020.
Mauduit J, Bukh, N, Vert M. (1993) Gentamycin/poly (lactic cid) blends aimed at sustained release local antibiotic therapy administered per-operatively: III. The case of gentamycin sulfate in films of high and low molecular weight poly (DL-lactic acid). Journal of Controlled Release..25, 43-49.
Maulding HV, Tice TR, Cowsar DR, Fong JW, Pearson JE Nazareno JP. (1986) Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. Journal of Controlled Release.;3, 103-17.
Maulding, HV. (1987) Prolonged delivery of peptides by microcapsules. Journal of Control Release 6, 167-176
Middleton JC, Tipton AJ. (2000). Synthetic biodegradable polymers as orthopaedic devices. Biomaterials. 21, 2335-2346.
Miller RA, Brady JM, Cutright DE. (1997). Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. Journal of Biomedical Materials Research.11, 711-719.
Mitra A, Lee CH, Cheng K. Advanced drug delivery. John Wiley & Sons. Wiley editors; 2013.
Naghipoor J, Ferreira JA, Oliveira P, Rabczuk T. (2016). Tuning polymeric and drug properties in a drug eluting stent: A numerical study. Applied Mathematical Modeling. 40, 8067-8086.
Pamula E, Blazewicz M, Chomyszyn-Gajewska M. (2000). Polymer-carbon composite for guide tissue regeneration. Engineering Biomaterials.10, 3-8.
Pitt CG, Gu Z. (1987). Modification of the rates of chain cleavage of poly (e-caprolactone) and related polyesters in the solid state. Journal of Controlled Release.4, 283–292.
Prabu P, Dharmaraj N, Aryal S, Lee BM, Ramesh V, Kim HY.(2006) Preparation and drug release activity of scaffolds containing collagen and poly(caprolactone). Journal of Biomedical Materials Research A.79, 153–158.
Raman C, Berkland C, Kim K. Pack DW. (2005). Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution. Journal of Controlled Release.103, 86-93.
Rossi S, Azghani A.O, Omri A. (2004). Antimicrobial efficacy of a new antibiotic-loaded poly(hydroxybutyric-co-hydroxyvaleric acid) controlled release system. Journal of Antimicrobial Chemotherapy.;54, 1008-1013.
Schiavone A, Zhao GL. (2015). A sudy of ballon type, system constraint and artery constitutive model used in finite element simulation of stent deployment. Mechanisc Advanced Materials and Modern Processes.;1, 1-15.
Siempmann J, Faisant N, Benoit JP. (2002). A new mathematical model quantifying drug release from bioerodible micro-particles using Monte Carlo simulations. Pharmaceutics Research.;19,1885-1893.
Steven J, Jonathan B, Kayla M, Karen I, Kathryn W, Nily D. (2006). Effect of drug type on the degradation rate of PLGA matrices. Biomaterials. 64, 287-293.
Subbu V. Release profiled in drug-eluting stents: Issues and uncertainties. (2007). Journal of Controlled Released. 120, 3149-3160.
Susan H, Cameron R.E. (2002). The effect of initial polymer morphology on the degradation and drug release from polyglycolide. Biomaterials. 23, 2401-2409.
Tae Gwan P. (1994). Degradation of poly (D, L-lactic acid) microspheres: effect of molecular weight. Journal of Controlled Released. 30, 161-173.
Tamburino C, Di Salvo M.E, Capodanno D, Capranzano P, Parisi R, Mirabella F.(2009). Real world safety and efficacy of the janus tacrolimus-eluting stent: long-term clinical outcome and angiographic findings from the tacrolimus-eluting stent (TEST) registry. Catheterization and Cardiovascular Interventions.73, 243–248.
Teja S.B, Patil S.P, Shete G, Patel S, Bansal A.K. (2013). Drug-excipient behavior in polymeric amorphous solid dispersions. Journal of Excipients and Food Chemicals.4,70–94.
Tiainen J, Veiranto M, Suokas E, Tormala P, Waris T, Ninkoviv M, Ashammakhi N. ( 2002) Bioabsorbable ciprofloxacin-containing and plain self-reinforced poly (lactidepolyglycolide 80/20 screws: pullout strength properties in human cadaver parietal bones. Journal of Craniofacial Surgery.13,427-433.
Vasconcellos LA, Santos LA. (2013). Calcium Phosphate Cement scaffolds with PLGA fibers. Polymer.33, 1032-1040.
Vert M, Chabot F, Leray J, Christel P. (1981). Stereoregular bioresorbable polyesters for orthopaedic surgery. Macromolecular Chemistry Supplement.5, 30–41.
Wang N, Wu X.S., Lujan-Upton H, Donahue E, Siddiqui A. (1997). Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid oligomer: I Synthesis and characterization. Journal of Biomaterials Science.8, 905-917.
Wang X, Venkatraman SA, Boey FY, Loo JS, Tan L.P. (2006). Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials.27, 5588-5595.
Wang Z.Y, Zhao Y.M, Wang F. (2006). Syntheses of poly (lactic-co-glycolic acid) serial biodegradable polymer materials via direct melt polycondensation and their characterization. Journal of Applied Polymer Science.99, 244-252.
Winter R, Katagiri Y, Asano T, Milewski KP, Lurz P, Buszman P, Jessurun GA Koch KT, Roland P Troquay T, Hamer B, Ophuis TO, Wöhrle J, Wyderka R, Cayla G, Hofma SH, Levesque S, Żurakowski A, Fischer D, Kośmider M, Goube P, Arkenbout EK, Noutsias M, Ferrari MW, Onuma Y, Wijns W, Serruys PW. (2018). A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomized, single-blind, multicenter non-inferiority, phase 3 trial. The Lancetr.391, 431-440.
Yang Y, Jiayan Lei, Wei Huang, Han Lei. (2016). Efficacy and safety of biodegradable polymer sirolimus-eluting stents versus durable polymer drug-eluting stents: A meta-analysis of randomized trials. International Journal of Cardiology.222, 486-493.
Zhu X, Braatz RD. (2015). A mechanistic model for drug release in PLGA biodegradable stent coating couple with polymer degradation and erosion. Journal of Biomedical Materials Research A.103, 2269-2279.
How to Cite
Valarezo-Ulloa, M., Chairez-Oria, J., Martínez-Mejía, G., García-Pérez, B., del Río, J., Gómez-Yañez, C., & Corea, M. (2020). Degradation study of copolymers of PLLGA to be used as potential polymeric matrix in coronary stents. Revista Mexicana De Ingeniería Química, 19(Sup. 1), 413-427.